Clinical Trials Browser

Recurrence × Ifosfamide × 90 days × Clear all

NCT05533775 2026-05-04

iMATRIX GLO

Phase 1/2 Recruiting

Recurrence

NCT00864318 2026-04-14

TICE

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Recurrence

NCT03458260 2026-03-10

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Phase 2 Completed

Recurrence, Lymphoma, Large B-Cell, Diffuse